NO20051601L - Kombinasjonsterapi med gemcitabin og zd6126 - Google Patents

Kombinasjonsterapi med gemcitabin og zd6126

Info

Publication number
NO20051601L
NO20051601L NO20051601A NO20051601A NO20051601L NO 20051601 L NO20051601 L NO 20051601L NO 20051601 A NO20051601 A NO 20051601A NO 20051601 A NO20051601 A NO 20051601A NO 20051601 L NO20051601 L NO 20051601L
Authority
NO
Norway
Prior art keywords
gemcitabine
human
combination therapy
warm
treated
Prior art date
Application number
NO20051601A
Other languages
English (en)
Norwegian (no)
Inventor
Alan Barge
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20051601L publication Critical patent/NO20051601L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
NO20051601A 2002-10-09 2005-03-30 Kombinasjonsterapi med gemcitabin og zd6126 NO20051601L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0223379.9A GB0223379D0 (en) 2002-10-09 2002-10-09 Combination therapy
PCT/GB2003/004328 WO2004032939A1 (en) 2002-10-09 2003-10-06 Combination therapy with gemcitabine and zd6126

Publications (1)

Publication Number Publication Date
NO20051601L true NO20051601L (no) 2005-04-22

Family

ID=9945537

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051601A NO20051601L (no) 2002-10-09 2005-03-30 Kombinasjonsterapi med gemcitabin og zd6126

Country Status (15)

Country Link
US (1) US20060058260A1 (de)
EP (1) EP1562610B1 (de)
JP (1) JP2006504722A (de)
KR (1) KR20050055758A (de)
CN (1) CN1703225A (de)
AT (1) ATE339209T1 (de)
AU (1) AU2003274306B2 (de)
BR (1) BR0315087A (de)
CA (1) CA2500906A1 (de)
DE (1) DE60308403T2 (de)
GB (1) GB0223379D0 (de)
MX (1) MXPA05003625A (de)
NO (1) NO20051601L (de)
WO (1) WO2004032939A1 (de)
ZA (1) ZA200502759B (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9714249D0 (en) * 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
US6537585B1 (en) * 1999-03-26 2003-03-25 Guilford Pharmaceuticals, Inc. Methods and compositions for treating solid tumors
US6291504B1 (en) * 1999-10-20 2001-09-18 Dupont Pharmaceuticals Company Acylsemicarbazides and their uses
ES2243466T3 (es) * 2000-03-31 2005-12-01 Angiogene Pharmaceuticals Ltd Terapias en dosis divididas con actividad dañina vascular.
EE200200565A (et) * 2000-03-31 2004-06-15 Angiogene Pharmaceuticals Ltd. Vaskulaarse kahjustava toimega kombinatsioonravi

Also Published As

Publication number Publication date
DE60308403T2 (de) 2007-09-06
CA2500906A1 (en) 2004-04-22
KR20050055758A (ko) 2005-06-13
WO2004032939A1 (en) 2004-04-22
DE60308403D1 (de) 2006-10-26
JP2006504722A (ja) 2006-02-09
BR0315087A (pt) 2005-08-16
CN1703225A (zh) 2005-11-30
ATE339209T1 (de) 2006-10-15
GB0223379D0 (en) 2002-11-13
AU2003274306B2 (en) 2007-02-08
EP1562610B1 (de) 2006-09-13
US20060058260A1 (en) 2006-03-16
AU2003274306A1 (en) 2004-05-04
EP1562610A1 (de) 2005-08-17
MXPA05003625A (es) 2005-06-03
ZA200502759B (en) 2006-06-28

Similar Documents

Publication Publication Date Title
DK1551409T3 (da) Anvendelse af quinazolinderivatet ZD6474 kombineret med gemcitabin og eventuelt ioniserende stråling ved behandling af cancer
NO20082567L (no) Kombinasjon av ZD6474 og pemetrexed
MX2007003505A (es) Combinacion que comprende zd6474 e imatinib.
MX2007003506A (es) Terapia de combinacion de cancer que comprende azd2171 e imatinib.
CY1111482T1 (el) Συνδυασμος azd2171 και πεμετρεξεδης
MXPA05008583A (es) Terapia de combinacion de zd6474 con 5-fu y/o cpt-11.
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
DK1653964T3 (da) Cancerkombinationsterapi omfattende AZD2171 og ZD1839
NO20064755L (no) Kombinasjonsterapi
NO20056171L (no) Kombinasjonsterapi
NO20064754L (no) Kombinasjonsterapi
WO2007003933A3 (en) Combination therapy of cancer with azd2171 and gemcitabine
ATE339209T1 (de) Kombinationstherapie mit gemzitabin und zd6126